首页> 中文期刊> 《中国药理学与毒理学杂志》 >Network pharmacology deciphering multiple mechanisms of volatiles of Wendan granule for treatment of senile dementia

Network pharmacology deciphering multiple mechanisms of volatiles of Wendan granule for treatment of senile dementia

         

摘要

OBJECTIVE To explore the mechanisms of the volatiles of Wendan granule for the treatment of senile dementia,network pharmacology method integrating absorption,distribution,metab-olism, and excretion (ADME) screening, target fishing, network constructing, pathway analyzing, and correlated diseases prediction was applied. METHODS Twelve small molecular compounds of WDG were selected as the objects from 74 volatiles with the relative abundances above 2%,and their ADME parameters were collected from Traditional Chinese Medicine Systems Pharmacology platform (TCMSP), and then the corresponding targets, genes, pathways and diseases were predicted according to the data provided by TCMSP,DrugBank,Uniport and the Database for Annotation,Visualization and Integrated Discovery(DAVID).The related pathways and correlation analysis were explored by the Kyoto Encyclo-pedia and Genomes (KEGG) database. Finally, the networks of compound-target, target-pathway and pathway-disease of WDG were constructed by Cytoscape software. RESULTS Twelve compounds interacted with 49 targets, of which top three targets were Gamma-aminobutyric acid receptor subunit alpha-1 (GABRA1), Prostaglandin G/H synthase 2 (PGHS-2) and Sodium-dependent noradrenaline transporter.Interestingly,these targets were highly associated with depression,insomnia and Alzheimer′s disease that mainly corresponded to mental and emotional illnesses. CONCLUSION The integrated network pharmacology method provides precise probe to illuminate the molecular mechanisms of volatiles of WDG for relieving senile dementia related syndromes,which will also facilitate the application of traditional Chinese medicine in modern medicine,as well as follow-up studies such as upgrading the quality stan-dard of clinical medicine and novel drug development.

著录项

  • 来源
    《中国药理学与毒理学杂志》 |2018年第4期|285-286|共2页
  • 作者单位

    Ministry of Education Key Laboratory of Chinese Medicine Resource and Compound Prescription;

    Ministry of Education Key Laboratory of Chinese Medicine Resource and Compound Prescription;

    Pharmacy School;

    Hubei University of Chinese Medicine;

    Institute of Geriatrics;

    Hubei University of Chinese Medicine;

    Wuhan 430065;

    China;

    Pharmacy School;

    Hubei University of Chinese Medicine;

    Institute of Geriatrics;

    Hubei University of Chinese Medicine;

    Wuhan 430065;

    China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号